The Use of Voriconazole as Primary Prophylaxis for Invasive Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation: A Single Center's Experience.

Ali AtouiNadine OmeiratOmar FakhreddineRaquelle El AlamZeina KanafaniIman Abou DalleAli BazarbachiJean El-CheikhSouha S Kanj

Published in: Journal of fungi (Basel, Switzerland) (2021)

Primary prophylaxis with voriconazole in allo-HCT is associated with a low incidence of IFI. More studies are required to compare various antifungal agents in this setting.

Keyphrases

stem cell transplantation
high dose
patients undergoing
risk factors
candida albicans
low dose
bone marrow
signaling pathway
cell proliferation
case control
cell wall